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From the Department ofNeuropathology, National Hospitalsfor Nervous Diseases, Maida Vale, London, UK SUMMARY The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3-8% to 12-8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease. (table 1) , if alternative Parkinsonian disorders are identified and excluded by pathological examination. Lewy bodies therefore provide a diagnostic marker and are as essential for the pathological diagnosis as the specific distribution of cell loss. The absence of Lewy bodies in even one bilateral 7 pm section of substantia nigra excludes Parkinson's disease.' Reports of Lewy bodies in individuals without rare disorders or rare variants of common disorders are also sometimes associated with Lewy bodies in the nervous system, usually in some of the same areas affected in idiopathic Lewy body disease (table 2) . These differ, however, because most are familial, occur at a young age and are associated with additional pathological lesions. In contrast to Parkinson's disease Lewy bodies are not invariably present; for example they are reported in only 10 ) . It should be distinguished from the Lewy body, because its appearance is less specific and is mimicked by neuronal changes in a variety of disorders including Table 2 Classification of Lewy body diseases ulations (pathoklisis)"5 and the apparent absence of transynaptic or retrograde degeneration is one of the main characteristics of the disease process. Cell loss is documented for most locations in which Lewy bodies occur and consequently the Lewy body is considered a marker of neuronal degeneration.
Structure and composition of the Lewy body
In pigmented cells of the substantia nigra and locus coeruleus the Lewy body is usually eosinophilic, intracytoplasmic, round and 5-25 pm in diameter. Most consist of a central body surrounded by a palestaining halo. Classical, but less common forms also have a darker centre (core) and/or darker rings (laminae) (fig la) . Lewy bodies also exist within nerve cell processes and free in the neuropil when released from a dying cell. Inclusions in nerve cell processes are common in the dorsal vagal nucleus and sympathetic ganglia, where they are frequently elongated or complex in shape. Ultrastructurally the body is formed from aggregated filament, [7] [8] [9] [10] [11] [12] [13] [14] [15] Pick's disease, corticobasal degeneration and even Alzheimer's disease and Steele-Richardson-Olszewski syndrome.
In view of the high degree of specificity of Lewy bodies their successful experimental induction could lead to advances in understanding the cellular abnormalities of Parkinson's disease. However, they have not been found in non-human primates and it has not been possible to induce them experimentally. 
son's disease, including the substantia nigra, locus coeruleus, dorsal vagal nucleus and EdingerWestphal nucleus. When these data are combined with that from four other studies reporting agespecific prevalence a surprisingly consistent increase between the sixth and ninth decades is obtained ( table  3; fig 2) . Some variation in prevalence rates between studies could result from selection of early Parkinsonian cases rather than reflecting real differences, but it is notable that in the Japanese and American studies Lewy 
Methods
In an attempt to clarify the size and characteristics of the population with incidental Lewy body disease we have examined 273 brains obtained from two sources. Two hundred were collected from hospital and community sources for standard neuropathological examination and were stored in two neuropathology laboratories. The remaining 73 cases were collected for the purpose of the study by one hospital necropsy service. After fixation in formol-saline part of the substantia nigra was blocked by horizontal cuts perpendicular to the axis of the brainstem passing ventrally between the oculomotor nerve and decussation of the superior cerebellar peduncle. After routine processing and embedding in paraffin wax one unilateral section, cut at 7 jm thickness, was prepared and stained with haematoxylin and eosin (H&E). Nerve cells in the sections were methodically 
Results
The 200 brains from neuropathology laboratories showed a variety of abnormalities, for example Huntington's chorea, Wernicke's encephalopathy, multiple sclerosis, cerebrovascular disease and trauma. Nine of Table 4 Age-specific prevalence rates of incidental Lewy body disease in this study (see fig. 3 ). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease decline in late age conflicts with many, but not all, epidemiological studies of Parkinson's disease. 36 It also suggests that the size of the population exposed at an earlier age to the pathogenetic factors for Lewy body disease is unknown. A prevalence of Lewy body disease over 1 in 10 of the population in their ninth decade and a progressive increase with time (age) implies that the size of this affected population may be considerable. Much of the current epidemiological evidence on prevalence rates of Parkinson's disease show rates which are approximately stable in time and between many of the different geographical locations examined. The cause of a disease to which over 10% of the population are exposed worldwide may therefore not be a single, common environmental factor."
In addition the probable exclusion of genetic38 factors for the cause of Parkinson's disease suggests that aetiological factors independent of simple environmental and genetic causes should be considered. These data do not however exclude the possibility that a common and universal environmental factor might contribute to the cause. The evidence linking normal ageing with Parkinson's disease is slim even if one considers age-related cell loss in addition to a diminished buffer reserve, which might be sustained in early life or represent a developmental abnormality. The speed of age-related cell loss in the substantia nigra (and other cell groups) has not been clearly established, but is probably not substantial. 39 An early life origin has been proposed in order to explain lifelong personality differences40 and onset of disease as early as the third decade.26 Probable lines of research should include a search for endogenous neurotoxins. Growth factors may also be involved and the antenatal period has been suggested as a potentially vulnerable time. 4' We are grateful to Dr R 0 Barnard and Professor P L Lantos for pathological material for this study. Seventy-three brains were collected through the UK Parkinson's Disease Society Brain Bank. We thank Dr B H Anderton for kindly supplying a number of cytoskeletal monoclonal antibodies. W R G G was supported by a Medical Research Council Grant.
